Y-Intercept (HK)’s Protalix BioTherapeutics PLX Stock Holding History

Y-Intercept (HK)’s Portfolio PLX Stock Details PLX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell
2024 Q4	$35.4K	Buy
2024 Q3	–	Sell
2024 Q2	$185K	Buy